ProjectSyndicate

NAS100 H3: PT 15 750 XABCD Bears: SHORT IT! (NEW)

Short
Why get subbed to me on Tradingview?

-TOP author on TradingView
-2000+ ideas published
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-before/after analysis
-24/7 uptime so constant updates

🎁Please hit the like button and
🎁Leave a comment to support our team!

NAS100/QQQ H3: PT 15 750 XABCD Bears: SHORT IT! (NEW)
IMPORTANT NOTE: speculative setup. do your own
due dill. use STOP LOSS. don't overleverage.
Tagged as SHORT because short-term I expect
more losses / 5% pullback off the highs.


🔸 Summary and potential trade setup
::: NAS100/QQQ H3 market overview/outlook
::: XABCD Bears in progress / speculative setups
::: BEARS short from overhead near 16 900
::: shorting makes sense
::: 5% pullback warranted off the highs
::: TP bears is 15 750 points
::: upside likely limited from here
::: means we will get more follow-through selling
::: STRATEGY: SHORT RIPS/RALLIES /NEAR D / PRZ
::: Bears TP is 15 750 points. 5% pullback.
::: Expecting MILD gains next 1-2 weeks
::: recommended strategy: SHORT IT / SHORT RIPS
::: hit resistance time to cool down a bit
::: no fast/miracle gains here - patience required
::: good luck traders
🔸 Supply/Demand Zones
::: N/A
::: N/A
🔸 Other noteworthy technicals/fundies
::: TD9 /Combo update: N/A
::: Sentiment short-term: BEARS/PULLBACK
::: Sentiment outlook mid-term: MIXED/RANGE

RISK DISCLAIMER:
Trading Crypto, Futures , Forex, CFDs and Stocks involves a risk of loss.
Please consider carefully if such trading is appropriate for you.
Past performance is not indicative of future results.
Always limit your leverage and use tight stop loss.

MY LINKS OVERVIEW
🟡 TAPLINK.CC/PRSYNDICATE
75% WINS FREE/PREMIUM SIGNALS TELEGRAM
🔴 T.ME/THESYNDICATE001
LIFETIME BUNDLE FX/CRYPTO
🟡 SYNDICATE001.CC/
FREE GOLD TRADING SIGNALS
🟡 T.ME/SYNDICATEGOLD001
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.